ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Intravenous PSA medications for adults

Intravenous PSA medications for adults
Medication Initial dose Onset (minutes) Duration (minutes) Repeat dose (as necessary) Comments
Propofol 0.5 to 1 mg/kg 0.5 5 0.25 to 0.5 mg/kg every 1 to 3 minutes
  • Sedative and amnestic. No analgesia.
  • Rapid onset and neurological recovery.
  • Useful in older adults without major comorbidities; reduce dose by ≥20% (maximum initial bolus: 0.5 mg/kg) and administer slowly (eg, over 3 to 5 minutes).
  • Respiratory depression, hypotension, and injection site pain may occur.
  • Contains egg lecithin, soybean oil (potential allergens; refer to UpToDate discussion of perioperative anaphylaxis).
Etomidate 0.1 to 0.15 mg/kg 5 to 15 seconds 5 to 15 0.05 mg/kg every 3 to 5 minutes
  • Sedative. No analgesia.
  • Generally maintains hemodynamic stability. Useful for patients at risk of hypotension.
  • In older adults or patients with impaired kidney or liver function, use doses at lower end of range.
  • Myoclonus, respiratory depression, injection site pain, and nausea/vomiting may occur.
Midazolam

0.02 to 0.03 mg/kg over 2 to 3 minutes

Usual individual dose: 0.5 or 1 mg and titrated to effect

Maximum single dose: 2.5 mg (1.5 mg in older adults)
2 to 5 30 to 60 May repeat after 2 to 5 minutes
  • Sedative and anxiolytic. No analgesia. Often combined with fentanyl for PSA.
  • Useful as a single agent when minimal sedation (anxiolysis) is required.
  • Relatively slow onset; requires more gradual initiation.
  • Prolonged effect or delayed recovery in older adults and patients with impaired liver or kidney function. Use lower doses and longer dosing intervals.
  • Use reduced dose in combination with other agents.
Fentanyl 0.5 to 1 mcg/kg 2 to 3 30 to 60 0.5 mcg/kg every 2 minutes (usual maximum cumulative dose: 5 mcg/kg or approximately 250 mcg)
  • Analgesic. No amnesia. Often combined with midazolam for PSA.
  • Minimal hypotension and histamine release.
  • Use reduced dose in combination with other agents (eg, maximum single dose: 0.5 mcg/kg).
  • May cause prolonged sedation in older adults or patients with impaired kidney or liver function; use lower doses (single and cumulative) and longer dosing intervals.
  • Respiratory depression may occur.
Ketamine 1 to 2 mg/kg over 1 to 2 minutes 0.5 10 to 20 0.25 to 1 mg/kg every 5 to 10 minutes (0.25 to 0.5 mg/kg if in combination with other sedatives)
  • Dissociative sedative, analgesic, and amnestic.
  • Minimal cardiorespiratory depression; does not inhibit protective reflexes. Useful for patients at risk of hypotension or with potentially difficult airway.
  • May be given intramuscularly; however, onset of sedation will be delayed by approximately 5 minutes.
  • Emergence reactions common in adults. Nausea and vomiting may occur.
  • Sympathetic stimulation, tachycardia, and hypertension may also occur (rare).
Dexmedetomidine

Bolus: 0.5 to 1 mcg/kg over 10 minutes

Infusion: 0.2 to 1 mcg/kg/hour
5 to 10 Post-continuous infusion: 60 to 240 minutes (dose dependent) Not applicable
  • Sedative. Some analgesia. Not amnestic.
  • Useful in patients with potentially difficult airway or when tachycardia or hypertension would be particularly dangerous.
  • May also be administered intranasally (2 to 3 mcg/kg) for anxiolysis and sedation when other routes are not optimal; however, onset of action is delayed.
  • Impaired liver function: use lower starting doses.
  • Decreased respiratory drive and airway obstruction can occur (rare).
  • Bradycardia and hypotension can occur with loading doses and during rapid dose titration (dose dependent); however, hypertension with loading doses and high-dose infusion has also been observed.
Methohexital 0.75 to 1 mg/kg 1 10 0.5 mg/kg every 2 to 5 minutes
  • Sedative and amnestic. No analgesia.
  • May cause prolonged sedation in older adults or patients with impaired kidney or liver function; use lower doses (single and cumulative) and longer dosing intervals.
  • Cardiorespiratory depression, hypotension, and tachycardia can occur.
  • Can precipitate or worsen seizures.

Older adults are at increased risk of adverse effects. Lower doses and less frequent administration are generally advised. Refer to UpToDate topic for discussion.

For patients with obesity, dosing based on modifications of actual (total) body weight (eg, ideal body weight, lean body weight) may be preferred to avoid oversedation. Refer to UpToDate topic for discussion.
PSA: procedural sedation and analgesia.
Data from: Gan, TJ Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet 2006;45(9):855-869. Falk, J, Zed, P, Etomidate for procedural sedation in the emergency department. Ann Pharmacother 2004;38:1272-7.
Graphic 52744 Version 4.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟